Healthcare provider profile · identity verified

Douglas S Ray, MD

Family Practice · PHOENIX, AZ · NPI 1295705788

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	533	184
Atorvastatin Calcium	Atorvastatin Calcium	533	179
Lisinopril	Lisinopril	346	117
Levothyroxine Sodium	Levothyroxine Sodium	314	103
Gabapentin	Gabapentin	283	104
Losartan Potassium	Losartan Potassium	274	93
Alendronate Sodium	Alendronate Sodium	232	79
Pantoprazole Sodium	Pantoprazole Sodium	229	77
Metformin Hcl Er	Metformin Hcl	224	77
Metoprolol Succinate	Metoprolol Succinate	201	70
Metformin Hcl	Metformin Hcl	178	63
Albuterol Sulfate Hfa	Albuterol Sulfate	167	66
Omeprazole	Omeprazole	159	55
Rosuvastatin Calcium	Rosuvastatin Calcium	156	63
Simvastatin	Simvastatin	156	50
Pioglitazone Hcl	Pioglitazone Hcl	148	57
Tamsulosin Hcl	Tamsulosin Hcl	147	48
Furosemide	Furosemide	122	54
Fluticasone Propionate	Fluticasone Propionate	114	50
Hydrochlorothiazide	Hydrochlorothiazide	113	40
Eliquis	Apixaban	112	20
Trazodone Hcl	Trazodone Hcl	109	45
Allopurinol	Allopurinol	107	34
Montelukast Sodium	Montelukast Sodium	105	40
Shingrix	Varicella-Zoster Ge/As01b/Pf	103	81
Terazosin Hcl	Terazosin Hcl	100	31
Glipizide	Glipizide	99	33
Glipizide Er	Glipizide	91	28
Metoprolol Tartrate	Metoprolol Tartrate	90	30
Ozempic	Semaglutide	88	22
Pravastatin Sodium	Pravastatin Sodium	88	29
Atenolol	Atenolol	83	27
Hydralazine Hcl	Hydralazine Hcl	83	30
Tizanidine Hcl	Tizanidine Hcl	76	35
Januvia	Sitagliptin Phosphate	75	19
Lactulose	Lactulose	75	31
Sertraline Hcl	Sertraline Hcl	75	28
Finasteride	Finasteride	74	24
Synthroid	Levothyroxine Sodium	74	26
Potassium Chloride	Potassium Chloride	70	24
Tramadol Hcl	Tramadol Hcl	69	16
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	66	66
Mirtazapine	Mirtazapine	66	31
Clopidogrel	Clopidogrel Bisulfate	65	25
Ibuprofen	Ibuprofen	63	26
Naproxen	Naproxen	63	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	63	21
Trulicity	Dulaglutide	61	11
Lantus	Insulin Glargine,hum.Rec.Anlog	59	14
Famotidine	Famotidine	58	20
Triamcinolone Acetonide	Triamcinolone Acetonide	53	31
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	51	51
Pregabalin	Pregabalin	51	20
Ezetimibe	Ezetimibe	50	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	20
Carvedilol	Carvedilol	46	17
Jardiance	Empagliflozin	43	12
Oxybutynin Chloride Er	Oxybutynin Chloride	42	15
Azelastine Hcl	Azelastine Hcl	39	11
Azithromycin	Azithromycin	39	36
Lovastatin	Lovastatin	39	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	33
Chlorthalidone	Chlorthalidone	38	13
Duloxetine Hcl	Duloxetine Hcl	37	12
Enalapril Maleate	Enalapril Maleate	37	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	16
Prednisone	Prednisone	36	27
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	20
Dicyclomine Hcl	Dicyclomine Hcl	33	11
Escitalopram Oxalate	Escitalopram Oxalate	33	12
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	31	12
Nifedipine Er	Nifedipine	30	11
Xarelto	Rivaroxaban	30	suppressed
Spironolactone	Spironolactone	29	14
Hydrocortisone	Hydrocortisone	28	20
Clonidine Hcl	Clonidine Hcl	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Ketoconazole	Ketoconazole	26	16
Klor-Con M20	Potassium Chloride	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Ondansetron Odt	Ondansetron	22	11
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	13
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Humalog	Insulin Lispro	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Pentips Pen Needle	Pen Needle, Diabetic	16	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	16	14
Lansoprazole	Lansoprazole	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Cephalexin	Cephalexin	11	11
Donepezil Hcl	Donepezil Hcl	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error